Last update 08 May 2025

INO-1800

Overview

Basic Info

Drug Type
DNA vaccine, Therapeutic vaccine
Synonyms
Target-
Action
stimulants
Mechanism
Gene transference, Immunostimulants
Therapeutic Areas
Infectious DiseasesDigestive System Disorders
Active Indication-
Inactive Indication
Hepatitis B, Chronic
Originator Organization
Inovio Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
Active Organization-
Inactive Organization
Inovio Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
License Organization
Roche Holding AGRoche Holding AGInovio Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with INO-1800
NCT02431312
/ CompletedPhase 1
Phase I, Randomized, Open-Label, Active-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability & Immunogenicity of INO-1800 Alone or in Combination With INO-9112 Delivered IM Followed by EP in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
100 Clinical Results associated with INO-1800
Login to view more data
100 Translational Medicine associated with INO-1800
Login to view more data
100 Patents (Medical) associated with INO-1800
Login to view more data
100 Deals associated with INO-1800
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis B, ChronicPhase 1
Thailand
Inovio Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
12 Jan 2015
Hepatitis B, ChronicPhase 1
Philippines
Inovio Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
12 Jan 2015
Hepatitis B, ChronicPhase 1
United States
Inovio Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
12 Jan 2015
Hepatitis B, ChronicPhase 1
Australia
Inovio Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
12 Jan 2015
Hepatitis B, ChronicPhase 1
Hong Kong
Inovio Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
12 Jan 2015
Hepatitis B, ChronicPhase 1
Singapore
Inovio Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
12 Jan 2015
Hepatitis B, ChronicPhase 1
New Zealand
Inovio Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
12 Jan 2015
Hepatitis B, ChronicPhase 1
Taiwan Province
Inovio Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
12 Jan 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free